Arch Therapeutics Inc (ARTH)

[Regis999]

The Company’s product, AC5, a liquid peptide, should result in faster, safer, simpler surgery with substantial savings in time of surgery (some have estimated potentially up to 60%).


"The operation would be much shorter. We go from a bypass surgery that may take six hours to a bypass surgery that may take 45 minutes. Or a neurosurgery that may take three or four hours, to one that takes 20 minutes. So, it completely changes how you think about surgery.” “And it’s not just hemostasis. If you look at surgery for instance, let’s say we create a barrier that will stop the movement of bacteria. It will stop the growth of bacteria, and if you could stop the possible infection in that operating room, the recovery time would be faster.”


http://www.pnas.org/site/misc/ellis-behnkePodcastTranscript.pdf